Blocking Extracellular Galectin-3 in Patients With Osteoarthritis

NCT02800629 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital